Your browser doesn't support javascript.
Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19.
Walle-Hansen, M M; Ranhoff, A H; Mellingsæter, M; Wang-Hansen, M S; Myrstad, M.
  • Walle-Hansen MM; Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, N-1346, Gjettum, Norway. marte@hansencorp.eu.
  • Ranhoff AH; Department of Medicine, Diakonhjemmet Hospital, Oslo, Norway.
  • Mellingsæter M; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Wang-Hansen MS; Department of Geriatric Medicine, Akershus University Hospital, Lørenskog, Norway.
  • Myrstad M; Department of Geriatric Medicine, Vestfold Hospital Trust, Tønsberg, Norway.
BMC Geriatr ; 21(1): 199, 2021 03 22.
Article in English | MEDLINE | ID: covidwho-1146623
ABSTRACT

BACKGROUND:

Older people are particularly vulnerable to severe COVID-19. Little is known about long-term consequences of COVID-19 on health-related quality of life (HR-QoL) and functional status in older people, and the impact of age in this context. We aimed to study age-related change in health-related quality of life, functional decline and mortality among older patients 6 months following hospitalisation due to COVID-19.

METHODS:

This was a cohort study including patients aged 60 years and older admitted to four general hospitals in South-Eastern Norway due to COVID-19, from March 1 up until July 1, 2020. Patients who were still alive were invited to attend a six-month follow-up. Change in HR-QoL and functional status compared to before the COVID-19 hospitalisation were assessed using the EuroQol 5-dimensional-5 levels questionnaire (EQ. 5D-5L). A change in visual analogue scale (VAS) score of 7 or more was considered clinically relevant.

RESULTS:

Out of 216 patients aged 60 years and older that were admitted to hospital due to COVID-19 during the study period, 171 were still alive 180 days after hospital admission, and 106 patients (62%) attended the six-month follow-up. Mean age was 74.3 years, 27 patients (26%) had experienced severe COVID-19. Fifty-seven participants (54%) reported a decrease in the EQ. 5D-5L VAS score after 6 months, with no significant difference between persons aged 75 years and older compared to younger. Seventy participants (66%) reported a negative change in any of the dimensions of the EQ. 5D-5L, with impaired ability to perform activities of daily life (35%), reduced mobility (33%) and having more pain or discomfort (33%) being the most commonly reported changes. Forty-six participants (43%) reported a negative change in cognitive function compared to before the COVID-19 hospitalisation. Six-month mortality was 21%, and increased with increasing age.

CONCLUSIONS:

More than half of the patients reported a negative change in HR-QoL 6 months following hospitalisation due to COVID-19, and one out of three experienced a persistently impaired mobility and ability to carry out activities of daily living. The results suggest awareness of long-term functional decline in older COVID-19 patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Aged / Humans / Middle aged Country/Region as subject: Europa Language: English Journal: BMC Geriatr Journal subject: Geriatrics Year: 2021 Document Type: Article Affiliation country: S12877-021-02140-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Aged / Humans / Middle aged Country/Region as subject: Europa Language: English Journal: BMC Geriatr Journal subject: Geriatrics Year: 2021 Document Type: Article Affiliation country: S12877-021-02140-x